Enteroendocrine cells are hormone-secreting cells spread along the intestinal epithelium. Their principal function is to promote the digestion of food. However, little is known about other functions that these cells may play, since they are difficult to study as a whole endocrine organ due to their diffuse localization. It is known that the intestinal epithelial barrier is actively involved in the host defense against pathogen invasion. Here we applied gene expression profiling to characterize the response of the human LCC-18 enteroendocrine cell line to physiological and pathological stimuli mimicked by fatty acids (FAs), flagellin and LPS exposure. We observed that these cells participate in an innate immune reaction to pathogens through the expression of pro-inflammatory factors (i.e. CXCL1 and 3 and IL-32) that we could validate by molecular and proteomic approach. Interestingly, IL-32 has been recently found over-expressed in the inflamed mucosa of patients affected by inflammatory bowel disease. This is very important because modifications of enteroendocrine cells during intestinal inflammation have been so far considered as secondary effects of the inflammatory status rather than due to direct pathogen/enteroendocrine cell interaction. As expected, FAs exposure up-regulates pro-differentiative genes and the production of cholecystokinin but it does not enhance the expression of pro-inflammatory genes. The present observations enlighten a new aspect of the cross talk between immune and endocrine system and suggest enteroendocrine cells as important contributors of inflammatory processes occurring in the gut in response to pathogen exposure and direct enhancers of the inflammatory status associated with human inflammatory bowel disease.
The gastrointestinal mucosa displays the largest body surface directly exposed to the external environment. In contrast to the skin, the gastrointestinal mucosa has no mechanical protection (i.e. stratum corneum) against external noxious agents as it lines as a monolayer of enterocytes intermixed with goblet and endocrine cells; the mucus produced by the goblet cells is believed to represent the only mechanical protection. The exposure of a large and vulnerable surface area (;250 m 2 ) to a high frequency of pathogens suggests the need for a sensitive surveillance system that could quickly react in response to dangerous signals.
Together with specialized immune cells, epithelial cells can contribute to such surveillance (i.e. enterocytes and Paneth cells). In mice, enteroendocrine cells were recently shown to participate in the innate immune response against pathogens by interacting with specific microbial patterns (1, 2) .
The luminal surface of enteroendocrine cells senses mechanical and/or chemical stimuli and translates them to the organism through the release of signaling peptides and amines. There are at least 14 types of enteroendocrine cells scattered throughout the gastrointestinal epithelium (3); one of their major functions is to coordinate an appropriate physiological response to food ingestion by detecting the nutrient composition (4) .
Inflammation can alter dramatically the physiology of the gut as in ulcerative colitis and Crohn's disease (5) in which alterations in motility, secretion and blood flow can cause diarrhea, cramping and pain. Although the involvement of the enteric nervous system and the gut-associated lymphoid tissue in this process has been well characterized, recent findings suggest that enteroendocrine cells can participate in the process (6) . It was recently observed in a mouse model that intestinal inflammation induces an increase in number of enteroendocrine cells, suggesting a reaction of these cells to pro-inflammatory stimuli (7) (8) (9) . Moreover, recent morphological observations suggest that enteroendocrine cells may be directly activated by T lymphocytes present in the lamina propria (10) . Since the relationship between pro-inflammatory stimuli and the transcriptional activation of human enteroendocrine cells has not been characterized yet, nor it is known whether these cells can serve as harbingers of noxious agents, we investigated the effect of inflammatory stimuli such as CpG, flagellin (FLAG) and bacterial LPS on the human cell line LCC-18. This cell line has been derived from a well-differentiated neuroendocrine tumor of the colon, which conserved functional characteristics of differentiated cells of neuroendocrine lineage (11) . After stimulation, global transcriptional analysis was applied to assess functional links between neuroendocrine and immune activation. Negative and positive controls included LCC-18 cells that did not receive stimulation or were exposed to fatty acids (FAs) as a physiological stimulus representative of food intake.
Materials and methods

Cell culture
Human colon neuroendocrine LCC-18 cells (a kind gift from K. Ö berg, Uppsala University Hospital, Uppsala, Sweden) were maintained in RPMI 1640 (Invitrogen, Carlsbad, CA, USA) supplemented with 5% fetal bovine serum (FBS), 0.04 mg ml À1 transferrin, 1.09 ng ml À1 b-estradiol, 133 ll L À1 of insulin solution (10 mg ml À1 ) from bovine pancreas, 25 mM HEPES buffer, pH 8.2 (all from Sigma-Aldrich, St Louis, MO, USA) and 2.6 ng ml À1 hydrocortisone (Cambrex Bio Science, Verviers, Belgium). Cells were incubated at 37°C in a 5% CO 2 humidified environment.
For Toll-like receptor (TLR) stimulation, LCC-18 cells were cultured for 18 h in complete medium with either LPS from Escherichia coli (1 lg ml
À1
, Sigma-Aldrich) or FLAG from Salmonella typhimurium (100 ng ml À1 , InvivoGen, San Diego, CA, USA) or human-specific CpG-ODN 2006 (5#-TCGTCGTTTTGTCGTTTTGTCGTT-3#) (Coley Pharmaceutical Group, Ottawa, Canada) or FAs (1.5 mM tridecanoic acid, Sigma-Aldrich).
Total RNA extraction, reverse transcription and PCR Total RNA was isolated from 1 3 10 6 washed cultured cells using Perfect RNA TM Eukaryotic Mini Kit (Eppendorf, Hamburg, Germany). Total RNA was converted into cDNA as follows: 2 lg of total RNA, 1 ll of random primers (50 lg ml À1 ; Promega Corporation, Madison, WI, USA) and 2 ll of dNTP mix (10 mM each) (Eppendorf) were denatured at 65°C for 5 min; the reaction volume was brought to 20 ll by addition of 4 ll of retrotranscription-PCR buffer containing 25 mM Mg 2+ , 1.5 U ll À1 of cMaster RT Enzyme, 0.5 ll of Prime RNase inhibitor solution and nuclease-free water (cMaster RTplusPCR System, Eppendorf); after incubation at 50°C for 60 min, the reaction was stopped by incubation at 85°C for 5 min. Using cDNA, PCR was performed with 400 nM of primers, 200 lM of each dNTP and 2 U of cMaster PCR Enzyme Mix (Eppendorf).
The PCR for the amplification of TLR4 included a denaturation at 94°C for 2 min, followed by 38 cycles of denaturation at 94°C for 20 s, annealing at 53°C for 20 s, extension at 72°C for 50 s and a final extension at 72°C for 5 min. The PCR amplification of TLR5 included denaturation at 94°C for 2 min, followed by 30 cycles of denaturation at 94°C for 30 s, annealing at 62°C for 30 s, extension at 72°C for 30 s and a final extension at 72°C for 5 min. The PCR for the amplification of TLR9 included denaturation at 94°C for 5 min, followed by 30 cycles of denaturation at 94°C for 1 min, annealing at 60°C for 1 min, extension at 72°C for 1 min and a final extension at 72°C for 10 min. The strategy for CXCL3 amplification was similar but required 35 cycles. The PCR for CXCL1 included denaturation at 94°C for 2 min, followed by 35 cycles of denaturation at 94°C for 30 s, annealing at 60°C for 1 min, extension at 72°C for 1 min and a final extension at 72°C for 10 min. The PCR for the amplification of CCL20 included denaturation at 94°C for 2 min, followed by 40 cycles of denaturation at 95°C for 45 s, annealing at 55°C for 45 s, extension at 72°C for 2 min and a final extension at 72°C for 5 min. The PCR amplification of NK protein 4 (NK4)/IL-32 included denaturation at 96°C for 1 min, followed by 40 cycles of denaturation at 96°C for 1 min, annealing at 60°C for 1 min, extension at 72°C for 1 min and a final extension at 72°C for 5 min. The following primers (Primm, Milano, Italy) were used: TLR4 Fw 5#-CTGGCTGCATAAAGTATGGT-3# Rev 5#-ATAGATGTTGCTTCCTGCCA-3#; TLR5 Fw 5#-TCAAAC-CCCTTCAGAGAATCCC-3# Rev 5#-TTGGAGTTGAGGCTTAGT-CCCC-3#; TLR9 Fw 5#-CAACAACCTCACTGTGGTGC-3# Rev 5#-GAGTGAGCGGAAGAAGATGC-3#; CXCL1 Fw 5#-ATTCAC-CCCAAGAACATCCA-3# Rev 5#-CACCAGTGAGCTTCCTC-CTC-3#; CXCL3 Fw 5#-GCAGGGAATTCACCTCAAGA-3# Rev 5#-ACCCTGCAGGAAGTGTCAAT-3#; CCL20 Fw 5#-CTGCTT-TGATGTCAGTGCTGC-3# Rev 5#-TCACCCAAGTCTGTTTTGG-3# and NK4 Fw 5#-CCGAAGGTCCTCTCTGATGA-3# Rev 5#-CCGCCACTGTCTCCAGGTAG-3#.
Western blot analysis
Proteins were extracted from LCC-18 cells by incubation in lysis buffer (0.1 M NaCl, 0.01 M Tris-HCl, pH 7.6, 0.001 M EDTA, pH 8), 1% Triton and 0.5 ng ml À1 leupeptin, 1 ng ml À 1 pepstatin, 2 ng ml À1 aprotinin and 100 lg ml À1 phenylmethylsulfonyl fluoride (all reagents by Sigma-Aldrich) on ice for 45 min. Proteins were quantitatively estimated using the BCA Protein Assay Kit (Pierce, Rockford, IL, USA). Protein samples (15 lg) were fractionated on a 8% acrylamide (Bio-Rad Laboratories, Hercules, CA, USA) slab gel containing 0.1% SDS (Sigma-Aldrich) and transferred onto a nitrocellulose filter (Amersham Bioscience, Buckinghamshire, UK) by electroblotting. After incubation for 1 h in Tris-buffered saline (TBS) with 1% Tween 20 (Sigma-Aldrich) and 5% milk powder to block non-specific binding sites, the filter was incubated with primary antibodies directed to TLR4 (goatpolyclonal anti-human, Santa Cruz Biotechnology, Santa Cruz, CA, USA) (1:100 in TBS with 5% milk powder) for 1 h and to TLR5 (rabbit polyclonal anti-human, Santa Cruz Biotechnology) (1:100 in TBS with 5% milk) for 45 min. After three washes for 20 min each in TBS, 1% Tween 20 and 5% milk powder, the filter was incubated with secondary antibody in TBS, 0.1% Tween 20 and 5% milk powder for 1 h at room temperature (RT). Secondary antibodies were: antigoat peroxidase-conjugated antibody for TLR4 (1:1000) and anti-rabbit peroxidase-conjugated antibody for TLR5 (1:1000) (both Vector Laboratories, Burlingame, CA, USA). To detect the TLR9 signal, the filter was incubated for 1 h in TBS with 5% milk with a primary mouse mAb (HBT, Uden, The Netherlands), washed in TBS for 5 min, incubated with biotinylated mAb to TLR9 (1:25 in TBS) for 1 h, washed 3 times in TBS-1% Tween and examined using the ABC Kit (Vector Laboratories). Bands were visualized using ECL TM Western Blotting Detection Reagents and autoradiography film (Amersham Biosciences, Piscataway, NJ, USA).
Western blot analysis was also performed on LCC-18 supernatants obtained from differentially treated cells in order to confirm the CXCL1 and NK4/IL-32 production and to test the specificity of the antibodies. Primary antibodies are the same used for ELISA. Briefly, cells were plated as described in NK4/IL-32 ELISA method and after 48 h 10 ll of medium from LPS-or FLAG-treated or untreated cells were separated in a 12% acrylamide (Bio-Rad Laboratories) slab gel containing 0.1% SDS (Sigma-Aldrich) and transferred onto a nitrocellulose filter (Amersham Bioscences). After blocking, membranes were incubated overnight at 4°C in TBS/0.1% Tween 20 with 5% non-fat dry milk with the primary antibody diluted 1:100 for NK4/IL-32 or 1:250 for CXCL1. As secondary antibodies, we used HRPconjugated goat anti-rabbit or horse anti-mouse diluted 1:1000. Membranes were washed and treated as already described.
Immunofluorescence microscopy analysis LCC-18 cells were subcultured on cover glass in 24-well plates, washed with PBS for 5 min and fixed for 5 min in 4% PFA, 2% saccharose in PBS (TLR4 and TLR9) or in 2% PFA in PBS (TLR5). After washing once in PBS, cells were incubated for 60 min at RT with the primary antibodies diluted 1:20 in saponin buffer (0.2% saponin and 0.5% BSA, Sigma-Aldrich) for TLR4 and TLR5 and 1:50 in the same buffer for TLR9. After washing with saponin buffer, cells were incubated for 1 h at RT with secondary antibody donkey antigoat-TRITC (Jackson ImmunoResearch Laboratories, West Grove, PA, USA) (1:500 in saponin buffer) to detect TLR4, with goat anti-rabbit-TRITC (Jackson ImmunoResearch Laboratories) (1:100 in saponin buffer) to detect TLR5 or with goat anti-mouse-TRITC (Molecular Probes, Eugene, OR, USA) (1:200 in saponin buffer) to detect TLR9. Cells were then washed with PBS, incubated with 4#,6-diamidino-2-phenylindole (1:50 000 in PBS) for 5 min and washed again with PBS. Slides were mounted with Mowiol (Calbiochem, La Jolla, CA, USA) and analyzed with the fluorescence microscope Nikon Eclipse 80i (Nikon, Tokio, Japan) equipped with a camera DS 5M (Nikon).
Flow cytometry
TLRs expression in LCC-18 cells was also confirmed by FACS analysis. Cells were harvested and fixed in 4% PFA buffered with 2% sucrose in PBS for 5 min at 4°C. After one wash with PBS and one in saponin buffer, incubation with primary antibody was performed for 1 h at RT. Goat antihuman TLR4 and goat anti-human TLR5 were purchased from Santa Cruz Biotechnology (sc-8694 and sc-8695, respectively). Mouse anti-TLR9-FITC was from Imgenex, San Diego, CA, USA (IMG-305C). As negative controls, the preimmune serum corresponding to the primary antibody (for TLR4 and 5) and mouse IgG FITC for TLR9 were used. Antibodies and sera were diluted 1:20 in saponin buffer. For TLR4 and 5 detection, after washing with PBS:saponin buffer 1:1, cells were incubated for 30 min at 4°C with the secondary antibody donkey anti-goat-FITC or TRITC, respectively (both from Jackson ImmunoResearch Laboratories). After washing with PBS/saponin buffer, cells were analyzed by flow cytometry (FACSCalibur, BD Biosciences, San Jose, CA, USA). Data were analyzed using CELLQUEST software (BD Biosciences).
NK4/IL-32 and CXCL1 ELISA
LCC-18 cells were plated in 24 multiwell plates and when at 70% confluence were treated with LPS or FLAG or left untreated, as previously described, in 300 ll of culture medium. After 24, 48, 72, and 96 h, 20 ll of supernatant were collected from each well and frozen at À20°C. At day 4, all the supernatants were tested with ELISA. Briefly, 96 multiwell plate wells were coated with 10 ll of supernatant overnight at 4°C. After 3 washes with 0.5% Tween 20 in PBS, incubation with primary antibodies diluted in 300 ll of assay diluent (10% FBS and 0.5% Tween 20 in PBS) was performed for 1 h at RT. The antibodies used in this test were 5 lg ml À1 rabbit polyclonal antihuman IL-32 (ab37158) and 1 lg ml À1 mouse monoclonal anti-human CXCL1/Groa (ab10375), both from Abcam, Cambridge, UK. After 3 washes, wells were incubated with the biotinylated proper secondary antibody (dilution 1:1000 in diluent buffer) for 1 h at RT and after 7 washes the reaction was developed with 3,3#,5,5#-tetramethylbenzidine and blocked with H 2 SO 4 . OD were read with Multiskan Ascent ELISA Reader from Thermo Electron corporation, Waltham, MA, USA.
Microarray analysis
RNA preparation, amplification, labeling and hybridization. Total RNA from test PBMC from normal donors was extracted and amplified into anti-sense RNA as previously described (aRNA) (12) (13) (14) . Total RNA from PBMC pooled from six normal Caucasian individuals not part of the present protocol was extracted and amplified into aRNA to serve as constant reference (12, 14) . Test (LCC-18 cells treated with different agents) and reference RNAs were labeled with Cy5 (red) and Cy3 (green), respectively, and
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co-hybridized to a custom-made 17.5 K cDNA (UniGene cluster) microarray. Microarrays were printed at the Immunogenetics Section, DTM, CC, NIH, with a configuration of 32 3 24 3 23 and contained 17 500 elements. Clones used for printing included a combination of the Research Genetics RG_HsKG_031901 8k clone set and 9000 clones selected from the RG_Hs_seq_ver_070700 40k clone set. The 17 500 spots included 12 072 uniquely named genes, 875 duplicated genes and ;4000 expression sequence tags.
Slides were scanned on a GenePix 4000 Scanner (Axon Instruments, Foster City, CA, USA) at variable PMT voltage to obtain maximal signal intensities with <1% probe saturation. Resulting tiff images were analyzed via GenePix pro 4.0 software. Data were analyzed using Cluster and TreeView software as described by Eisen et al. (15) .
The present paper refers to an experiment done in triplicate for each treatment, and data were confirmed by another independent experiment performed in triplicate as well. The projects reporting all the intensity values obtained from the single slides as well as the detailed MIAME array description are available as Supplementary Data at International Immunology Online.
Statistical analysis
The raw data were filtered to exclude spots with minimum intensity by arbitrarily setting a minimum intensity requirement of 300 in both fluorescence channels. If the fluorescence intensity of one channel was over and that of the other below 300, the fluorescence of the low-intensity channel was arbitrarily set to 300. Spots with diameters <25 lm and flagged spots were excluded from the analysis. The filtered data were then normalized using the lowess smoother correction method. All statistical analyses were performed using the log 2 -based ratios normalizing the normal value in the array equal to zero.
Validation and reproducibility were measured using an internal reference concordance system based on the expectation that results obtained through the hybridization of the same test and reference material in different experiments should perfectly collimate. The level of concordance was measured by periodically re-hybridizing the melanoma cell line A375-melanoma (American Type Culture Collection, Rockville, MD, USA) to the reference samples consisting of pooled PBMC as previously described (16) . This analysis demonstrated a >95% concordance level. Non-concordant genes were excluded from subsequent analysis.
Supervised class comparison was performed using the BRB ArrayTool (17) developed at National Cancer Institute, Biometric Research Branch, Division of Cancer Treatment and Diagnosis. Samples were tested with a two-tailed unpaired Student's t-test assuming unequal variance. Analyses were tested for a univariate significance threshold set at a P 2 value <0.005 if not differently specified. Gene clusters identified by the univariate t-test were challenged with two alternative additional tests, a univariate permutation test (PT) and a global multivariate PT. The multivariate PT was calibrated to restrict the false discovery rate to 10%. Genes identified by univariate t-test as differentially expressed (P 2 value <0.005) and a PT significance <0.05 were considered truly differentially expressed. Gene function was assigned based on Database for Annotation, Visualization and Integrated Discovery (18) and Genontology (17) .
Results
Gene expression analysis
Array data were first queried to display segregation of samples based on an F test comparison across the various experimental conditions (Fig. 1A) using as a cut-off of significance a P value of <0.005. This analysis identified 137 genes discriminating the different treatment categories with the exception of CpG-stimulated samples which clustered in proximity of the non-treated control samples, suggesting that CpG in the model, conditions and concentrations tested here has minimal effects on neuroendocrine cells. FA-stimulated cells strongly differed from all the other samples underlying the high specificity of LCC-18 response to the physiological exposure to a nutrient. Samples stimulated with TLR agonists such as LPS (TLR4 ligand) and FLAG (TLR5 ligand) clustered together separately from FAs as well as untreated samples.
Stimulation with FAs
FAs are the physiological stimulator of enteroendocrine cells, mimicking the presence of food in lumen of the gut. As expected, FAs induced a broad array of transcriptional changes leading to a high number of up-and down-regulated genes ( Table 1) . Many of the genes induced by FAs are functionally involved in cell cycle and cell differentiation. It is known that FAs can generically stimulate the production of secretory molecules by increasing vesicle exocytosis and represent an important source of energy through their oxidation, but to our knowledge, this is the first gene expression analysis of enteroendocrine cells exposed to FA stimulation.
The up-regulation of different pro-differentiative genes and down-regulation of pro-proliferative genes are among the main effects of FAs at the transcriptional level. Interestingly, the expression of Kruppel-like factor 4, a molecule typically expressed in differentiated intestinal epithelial cells, was found to be up-regulated. As expected, cholecystokinin (CCK), which is the typical product of enteroendocrine cells in response to FA stimulation, was found to be consistently up-regulated (Fig. 1C) .
LPS-and FLAG-regulated genes
To better distinguish the differentiation-specific response induced by various TLR agonists, we eliminated from the analysis the samples treated with FAs and compared untreated samples with TLR agonists-stimulated samples. This analysis enhanced differences among TLR-stimulated samples. The different experiments continued to cluster according to treatment, although, in this case, CpG-treated samples (Fig. 1B) approximated even more closely untreated samples.
This observation suggested that at least in the experimental conditions and agent doses tested here, LPS and FLAG induced more consistent activation of enteroendocrine cells than CpG while they are similar to each other in spite of the different TLR specificity.
Interestingly, LPS and FLAG strongly up-regulated the expression of molecules involved in immune responses and in particular cytokine signaling (Fig. 1D and Table 2 ). For example, CXCL1 and 3 are ligands for IL-8 receptor beta and are involved in the localization and activation of neutrophils and basophils. This observation was also confirmed by PCR (Fig. 2) . Another finding supporting this hypothesis is the up-regulation of the NK4, recently renamed IL-32. This molecule was found over-expressed in the inflamed mucosa of patients affected by inflammatory bowel disease (19) . The present observations suggest that enteroendocrine cells may contribute and enhance directly the inflammatory process in response to pathogen exposure. The actual secretion of CXCL1 and NK4/IL-32 was confirmed by testing with ELISA supernatants from LCC-18 cells stimulated 1, 2 or 3 days with LPS or FLAG or left untreated (Fig. 2) . Interestingly, the intensity of the ELISA signal mirrors the difference in mRNA amount that can be qualitatively appreciated in Fig. 3 from PCR results.
The up-regulation of IFN alpha-inducible protein 6 and of the granulocyte-macrophage colony-stimulating factor (GM-CSF) is also a sign of the sensitivity of these cells to immune-modulator molecules.
TLRs expression
The stimuli were selected in order to mimic bacterial exposure (LPS, FLAG and CpG) and to target different TLRs (TLR4, 9 and 5, respectively). TLRs expression was tested by PCR, western blot, immunofluorescence and FACS analysis (Fig. 4A, B and C, respectively) confirming their presence at both transcriptional and protein level. This result is also supported by previous data obtained on STC-1 cells, a murine enteroendocrine cell line (1) . As a positive control for TLRs transcription and translation (PCR and western blot analysis), we used cDNA and proteins extracted from primary culture of human gingival fibroblast (20) .
Discussion
In this study, we observed that the human enteroendocrine cell line LCC-18 expresses TLR4, 5 and 9 and that the presence of their ligands induces the production of inflammatory molecules. Our data confirm previous experiments showing Growth differentiation factor 15 Member of the TGFB1 superfamily, it regulates tissue differentiation and maintenance the presence of TLRs in a murine enteroendocrine cell line STC-1 (1, 2) and add broader information through gene expression analysis. The ligands used in this study were LPS, FLAG and CpG for TLR4, 5 and 9, respectively. LPS is a molecule present on the surface of gram-negative bacteria that are physiologically part of the gut microflora. This renders intriguing the possibility for the enteroendocrine cells to respond to this molecule. The dose we used mimics a very high bacterial charge, unusual in normal conditions and is the typical amount used as inflammatory stimulus in different in vitro models (21, 22) . In vivo the gut environment is highly tolerogenic, in order to avoid chronic inflammation due to the presence of commensal bacteria. Lotz et al. (23) report as the responsiveness to TLR4 in intestinal epithelial cells is present in the sterile condition during pregnancy but is lost after birth, when the gut is colonized.
In vitro such environment is not present and the lack of tolerogenic stimuli could render these cells more sensitive to pro-inflammatory molecules. This means that in vitro models can be useful for investigating the potential role of cells but the doses used for stimulation are only valid in that particular conditions and cannot be extrapolated for in vivo considerations since the picture can be very different due to the different microenvironment.
Knowledge about the up-regulation of pro-inflammatory genes after treatment with the TLR ligands LPS and FLAG can be very important for the study of intestinal pathologies related to inflammation. It is known that TLRs can play an important role in the development of inflammatory bowel disease (24) .
Particularly interesting is the increase in NK4/IL-32 expression following LPS and FLAG treatment. This molecule has been recently correlated with human autoimmune diseases and is better known as IL-32. Dinarello and Kim (25) reported that epithelial cells from healthy subjects express low levels of the cytokine, but in disease conditions such as chronic obstructive pulmonary disease, Crohn's disease and psoriasis, the expression increases markedly and its level of expression is correlated with disease severity. Although the present findings cannot conclusively support a major role of enteroendocrine cells in the development of Crohn's or inflammatory bowel diseases, the up-regulation of NK4/IL-32 after FLAG and LPS but not FA treatment strongly suggests the participation of these cells in the pathogenesis of these diseases. Netea et al. (26) showed that IL-32 is able to induce tumor necrosis factor (TNF)-a, IL-1b and IL-6 secretion in PBMC, especially monocytes, stimulating the nucleotidebinding oligomerization domain 2 (NOD2) pathway, while does not influence the cytokine production induced via TLRs. NOD2 is able to sense the presence of muropeptides, Fig. 2 . CXCL1 (A) and NK4/IL-32 (B) secretion detection by ELISA analysis. At day 1, 2, 3 and 4, 10 ll of supernatant from cells treated with LPS or FLAG or left untreated were collected and tested for cytokine production. White bars: untreated controls; light gray bars: LPS-treated cells; gray bars: FLAG-treated cells. The variation of the cytokine production was calculated as fold increase of the measured OD in comparison with the mean value of the OD of the controls. Statistical significativity of values is expressed as P value calculated for each day between each treatment and its control **P < 0.005, *P < 0.05. (C) Western blot analysis performed on supernatants collected at 48 h from the start of the experiment were tested in order to confirm ELISA results and antibodies specificity. a product of the degradation of bacterial peptidoglycan, exerting an adjuvant activity and synergizing with LPS in the induction of pro-inflammatory responses in vitro and in vivo (27) . Interestingly, macrophages resident in the intestinal lamina propria are strongly down-regulated for the expression of innate immune receptors (i.e. LPS receptors) and the production of pro-inflammatory cytokines, while they retain phagocytic and bactericidal activity in non-inflamed mucosa (28) . Our data suggest a cooperation between enteroendocrine cells and immune cells (particularly monocytes and neutrophils): enteroendocrine cells are able to sense the presence of LPS or FLAG in the lumen, produce chemo attractant molecules able to recruit immune cells from the lamina propria (CXCL1 and 3 and CCL20) and activate them through NK4/IL-32 stimulation that leads to the production of TNF-a via NOD2 and triggers in this way an escalation in the inflammatory state. Moreover, the close relationship between these two cell types is supported by the fact that they share receptors like the GM-CSF receptor. The validation of this hypothesis is at the moment under investigation but our finding can be very important since modifications of enteroendocrine cells during inflammatory bowel disease have been so far considered secondary effects of the inflammatory status rather than due to direct pathogen/enteroendocrine cell interactions.
Some authors proposed that inflammation affects enteroendocrine cells increasing their number and inducing their production of CCK (6), while others attribute to CCK an antiinflammatory effect (29, 30) . In the present study, we observe that enteroendocrine cells treated with pathogenmimicking stimuli show a down-regulated synthesis of CCK in comparison to FA stimulation. Comparison of LPS-and FLAG-treated cells with untreated cells demonstrated no significant change in CCK production. Our data suggest that the presence of pathogens in the lumen can switch (or at least push) the transcriptional machinery of these cells toward a defensive function. The shut off of CCK production during pathogen invasion could have a physiological significance since one of the effects of this hormone is the delay in stomach emptying and this could favor the bacterial infection (31) . On the contrary, a physiological stimulus like the presence of FAs induces pro-differentiative genes and the production of CCK but does not enhance the expression of pro-inflammatory genes.
The possibility of a cross talk between immune and the endocrine system is already accepted as a neuro-immuneendocrine network has been proposed that coordinates the three systems in order to maintain homeostasis and defend against the pathogens (32) . Our data open the new perspective that enteroendocrine cells may play a primary role in the induction of inflammation in human intestine. At this point, it is probably useful to remember that these cells, even if scattered as single cells among the epithelial cells lining the intestinal lumen and visually very difficult to localize, represent the largest population of hormone-producing cells in the body and constitute ;1% of the cells lining the intestinal lumen (33) . As a consequence, a massive production of molecules by these cells can strongly influence the intra-luminal and mucosal environment. Anatomically, enteroendocrine cells reach on one side the intestinal lumen, thanks to a protrusion of the cell cytoplasm squeezed among enterocytes while, on the other end, their proximity to the basal layer and the blood vessels provides a privileged position to sense and transmit stimulatory signals from the external intestinal environment to the systemic circulation.
In conclusion, our findings can enlighten new perspectives in the study of human diseases involving intestine inflammation and bring on the stage a too often under considered cell population that can instead play an important role in the intestine immunological homeostasis.
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